Displaying drugs 14526 - 14550 of 15111 in total
Tivanisiran
Tivanisiran is under investigation in clinical trial NCT03108664 (HELIX, a Double-masked Study of SYL1001 in Patients With Moderate to Severe Dry Eye Disease (DED)).
Investigational
Lapuleucel-t
Investigational
Redasemtide
Redasemtide is under investigation in clinical trial NCT05953480 (A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke).
Investigational
Baltaleucel-T
Investigational
EMI-137
EMI-137 is under investigation in clinical trial NCT03360461 (EMI-137 in Laparoscopic Colonic Resections).
Investigational
Atexakin alfa
Atexakin alfa is under investigation in clinical trial NCT05435742 (SON-080 in Patients With Persistent Chemotherapy-induced Peripheral Neuropathy (CIPN)).
Investigational
Lixudebart
Lixudebart, an investigational first-in-class monoclonal antibody, aims to reverse fibrosis.
Investigational
Bos taurus colostrum
Investigational
Ecklonia cava
Investigational
Stapuldencel
Investigational
Pseudomonas aeruginosa
Investigational
Cancer/testis antigen 1
Investigational
Human placenta hydrolysate
Investigational
Interleukin-12 human recombinant
Investigational
Bemiltenase alfa
Investigational
ION356
Investigational
BV2
Experimental
CRA_10991
Experimental
3h-Indole-5,6-Diol
Experimental
3-Methylpyridine
Experimental
Hydrogenobyrinic acid
Experimental
Indirubin-5-sulphonate
Experimental
Siroheme
Experimental
Displaying drugs 14526 - 14550 of 15111 in total